• LAST PRICE
    17,050.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    17,050.0000/ 1
  • Ask / Lots
    21,999.0000/ 1
  • Open / Previous Close
    --- / 17,050.0000
  • Day Range
    ---
  • 52 Week Range
    Low 2,849.5000
    High 49,895.0000
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesODTC
Odonate Inc
49.9M
-1,254.8x
---
United StatesLEXX
Lexaria Bioscience Corp
37.7M
-4.8x
---
United StatesCLRB
Cellectar Biosciences Inc
64.1M
-0.9x
---
United StatesAKTX
Akari Therapeutics PLC
30.7M
-0.4x
---
United StatesKALA
KALA BIO Inc
30.2M
-0.5x
---
United StatesPYPD
PolyPid Ltd
23.3M
-0.5x
---
As of 2024-11-22

Company Information

Odonate, Inc., formerly Odonate Therapeutics, Inc., is a pharmaceutical company. The Company is focused on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The Company is no longer in development of tesetax.

Contact Information

Headquarters
4747 Executive Drive Ste 210SAN DIEGO, CA, United States 92121
Phone
858-200-3830
Fax
302-655-5049

Executives

Chairman of the Board, Chief Executive Officer
Kevin Tang
Chief Financial Officer
Michael Hearne
Director
Robert Rosen
Independent Director
Aaron Davis
Independent Director
Laura Douglass

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$49.9M
Revenue (TTM)
$0.00
Shares Outstanding
2.9K
Odonate Inc does not pay a dividend.
Beta
0.09
EPS
$-13.59
Book Value
$17.65
P/E Ratio
-1,254.8x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.